NBEMS plans to increase PG seats to 25,000
Mangaluru: The
National Board of Examination in Medical Science
(NBEMS), which currently has around 17,000 seats, is making an effort to increase this number to 25,000 in a few years, said Dr Abhijat Sheth, president of NBEMS, ministry of health and family welfare, govt of India.
Dr Sheth was in the city to attend an annual convocation of a deemed-to-be university. In a conversation with TOI, he spoke about the increase in PG seats, the rationale behind the two shifts in the entrance exam, which is largely criticised, and the focus on PG specialities that are more required in the country.
Dr Sheth was instrumental in significantly increasing NBEMS PG seats from approximately 4,500 in 2016 to 17,000 to date. He said that this was possible because the board removed unnecessary barriers, especially by making the accreditation process simpler.
"We aim to increase to at least 25,000 by the end of 2030. However, there are challenges ahead. The board is strongly focusing on achieving a UG/PG ratio of 1:1.
This not only enhances access to human resources but also increases the quality of medical education and healthcare. We want to improve the overall healthcare system by achieving a 1:1 ratio. Many developed western countries have a 1:1 ratio (UG/PG)," Dr Sheth said.
Beyond increasing seat numbers, Dr Sheth focused heavily on enhancing skill training, digital eLearning, and faculty development programmes.
"With the advancement of technology and the increase in the complexity of medical treatment and diseases, we need to extend the scope of medical education beyond physical education, ideally complemented by skill and virtual learning," he said.
Regarding the decision to conduct NEET PG in two shifts, in 2024, the K Radhakrishnan committee reviewed the process and recommended that it should be held in govt-approved institutions and TCS-approved centres.
As a result, the board, which had 1,000 centres until 2023, reduced this to 450, which made it impossible to conduct a single-shift examination.
Sheth said that for the benefit of the Indian population, they are planning to increase PG as well as diploma courses in medicine, surgery, obstetrics and gynaecology, and critical care, to name a few important ones.
These are the demanded specialities in the country. "We have increased diploma courses from the existing nine to 10," he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
an hour ago
- The Hindu
Delhi HC sets aside appointment of NCISMC chairperson
The Delhi High Court on Friday (June 6, 2025) quashed the appointment of Vaidya Jayant Yeshwant Deopujari as Chairperson of the National Commission for Indian System of Medicine, holding that he does not meet the qualification prescribed for appointment to the office. The court passed the order on two petitions filed by Ved Prakash Tyagi, former president of the erstwhile Central Council for Indian Medicine, and Dr. Raghunandan Sharma challenging the appointment of Mr. Deopujari as the chairperson of the commission (NCISMC). The Ministry of Personnel, Public Grievances, and Pensions had issued a circular on June 9, 2021, appointing Mr. Deopujari as the commission's chairperson. The petitioners have alleged that Mr. Deopujari could not be appointed as the chairperson of the commission as he does not hold a postgraduate degree, mandated under the National Commission for Indian System of Medicine Act, 2020 (NCISM Act). The court held that Mr. Deopujari possessed a PhD degree, whereas the requisite degree was an MD or any other equivalent master's degree in any discipline of the Indian System of Medicine. The PhD degree that was awarded to him by Pune University did not presuppose acquisition of a lower qualification (Master's Degree in Ayurveda), it said. Ineligible person 'We have no hesitation to hold that the expression 'Post-Graduate Degree' occurring in Section 4(2) of the NCISM Act, 2020, in the context it has been used, would mean a Master's Degree (MD) in any discipline of Indian System of Medicine, which the respondent does not possess, and, therefore, he lacks the requisite qualification for being appointed to the office in question,' the court said. Mr. Tyagi's plea said the commission was a governing body for all matters relating to education and regulation of Indian medicine in the country. 'Thus, the interests of a large number of people/students/Indian medicine practitioners shall be adversely and severely affected if an ineligible person is allowed to continue as the chairperson of such a critical statutory body,' he added. The court noted that the counsel representing the Commission has stated in the court that the process of selection and appointment of the Chairperson of the Commission has commenced. 'Accordingly, we direct that the said process shall be completed with expedition, and while conducting the process of selection, the observations made hereinabove in this judgment shall be taken into account,' the court added.
Time of India
2 hours ago
- Time of India
Poinguinim boar attack victim compensated
Canacona: The forest department paid a compensation of Rs 85,000 to Jayanti Velip, who developed deformities from a wild boar attack in Jan. The compensation papers were prepared by the assistant conservator of forests (South) Harsh Phadte and range forest officer, Canacona, Anant Velip, under the supervision of the deputy conservator of forests (South), Satish Kumar Reddy. Velip was working in a paddy field at Velwada, Poinguinim when a wild boar attacked her from behind. She fought with the boar and suffered injuries, resulting in 82% disability to her thumb and ear, she told TOI . After the attack, she was hospitalised for over two months and is now unable to use her right thumb or hear properly with her one ear. Get the latest lifestyle updates on Times of India, along with Eid wishes , messages , and quotes !
Business Standard
2 hours ago
- Business Standard
G.C Chemie Pharmie: Four Decades of Innovation and Trust in Pharmaceuticals and Nutraceuticals
India PR Distribution Mumbai (Maharashtra) [India], June 6: G.C Chemie Pharmie Pvt. Ltd. (GCCPL), a pioneer in India's pharmaceutical, nutraceutical, functional foods, and biopharmaceutical sectors, proudly celebrates over 44 years of innovation and service excellence. Founded in 1981 by visionary entrepreneur Gautam Shah, GCCPL has evolved into a globally connected and innovation-driven enterprise known for its commitment to trust, transparency, and quality. What began as an API trading and distribution firm has transformed into a diversified pharmaceutical powerhouse. GCCPL's impressive timeline of achievements includes: - 2009/2010: Acquisition of Eagle Chemical Works, establishing its own API manufacturing capabilities - 2009: Release of its first vaccine, marking a significant milestone in biopharmaceuticals - 2010/2011: Launch of its P2P division, introducing affordable medicines to the Indian market -2018: Entry into the sports nutrition space - 2022: Creation of a preventive healthcare division with a focus on gynecology and orthopedics - 2023: Establishment of a dedicated vaccine division to expand immunization solutions Driven by a mission to lead through innovative thinking and technology adoption, GCCPL delivers tailored solutions across pharmaceutical, nutraceutical, and functional food categories. The company continues to differentiate itself through its strong regulatory acumen, cutting-edge R & D, and a global network of manufacturing and distribution partners. "At GCCPL, innovation is not a buzzword--it's the foundation of our growth strategy," said Founder and Chairman Gautam Shah. "We're proud to be one of India's few private companies to bring the pneumococcal vaccine to the domestic market, second only to Pfizer." Recent product highlights include UC-II®, a patented undenatured type II collagen supplement, and Pylopass™, a breakthrough strain-based probiotic--both showcasing GCCPL's commitment to introducing clinically backed, innovative health solutions to India. With a sterling reputation for regulatory compliance, deep market research, and financial integrity--as affirmed by CRISIL's highest rating A2+ GCCPL stands as a trusted partner for businesses and healthcare providers seeking reliable, next-generation healthcare products. About G.C Chemie Pharmie Pvt. Ltd. Founded in 1981, GCCPL is an Indian-based pharmaceutical and nutraceutical company with a global footprint. Known for its reliability, innovation, and commitment to quality, GCCPL offers customized, technology-driven healthcare solutions to meet the evolving needs of today's market. The company maintains a strong presence in vaccines, preventive care, functional foods, and advanced supplements.
